The sole study investigating mGluR5 and ketamine in relation to depression showed that ketamine reversed depressive-like behavior induced by viral overexpression of mGluR5 in the hippocampus (Wang et al. 2020). The gene discussed is GRM5; the disease is depressive symptom measurement.